查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1540819

2024-2032 年按測試類型、服務提供者、應用和地區分類的臨床實驗室服務市場報告

Clinical Laboratory Services Market Report by Test Type, Service Provider, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球臨床實驗室服務市場規模達到2,447億美元。對血糖測試、HbA1c 測試和血脂監測等糖尿病管理的診斷測試的需求不斷成長，越來越依賴遠距醫療來獲得臨床實驗室服務，因為它可以減少醫療保健障礙並增加總體測試量，並且精度趨勢不斷提高藥品對市場有正面影響。

臨床實驗室服務市場分析：

主要市場促進因素：對基因測試、基因組定序和分子診斷的需求不斷成長，以識別生物標記、遺傳變異和精準醫療的特定分子靶標，正在推動市場成長。

主要市場趨勢：遠距醫療的不斷成長趨勢使人們即使在偏遠地區也能獲得醫療保健服務，這提供了良好的市場前景。

地理趨勢：北美因其高度發展的醫療保健系統、先進的基礎設施和廣泛的醫療保健服務而享有領先地位。

競爭格局：臨床實驗室服務業的一些主要市場參與者包括 Abbott Laboratories、Becton、Dickinson and Company、bioMerieux SA、Charles River Laboratories、F. Hoffmann-La Roche Ltd、Illumina Inc.、NeoGenomics Laboratories Inc.、Quest Diagnostics Incorporated、Siemens Healthcare GmbH (Siemens AG)、Thermo Fisher Scientific Inc. 等。

挑戰與機會：雖然市場面臨監管合規、高營運成本以及維持測試準確性和可靠性等挑戰，但在診斷技術、個人化醫療和遠距診斷服務方面也遇到了機會。

臨床實驗室服務市場趨勢：

糖尿病盛行率上升

用於管理糖尿病的診斷測試（例如血糖測試、HbA1c 測試和血脂分析）的需求不斷增加。這些測試對於診斷糖尿病、監測血糖水平和評估相關心血管危險因子也至關重要。為了有效控制糖尿病，需要定期監測血糖值。臨床實驗室非常重要，因為它們可以幫助監測血糖控制、腎功能、血脂水平和其他生物標記。為了預防糖尿病視網膜病變、腎病變和神經病變等併發症，臨床實驗室會進行篩檢測試。這些篩檢測試可以及時干預，有助於預防糖尿病的進展。人們更喜歡即時檢測 (POCT)，因為它可以快速檢測並立即獲得結果。此測試對於監測糖尿病患者更為成功。根據IDF糖尿病圖譜網站公佈的資料，預計到2045年，約有7.83億人將患有糖尿病。

精準醫療需求不斷成長

IMARC Group的報告顯示，2023年全球精準醫療市場規模將達到752億美元。這些測試在臨床實驗室進行，因為它們有助於預測疾病風險、根據個體的遺傳特徵選擇最有效的療法並指導治療決策。為了開發和執行伴隨診斷，臨床實驗室非常重要，這正在加強臨床實驗室服務市場的成長。伴隨診斷是用於識別生物標記以計算任何特定標靶治療的成功率的測試。了解這一點後，可以最佳化腫瘤學、傳染病和其他治療領域的治療選擇。分析遺傳變異以監測個體對藥物的反應非常重要，而藥物基因組學在該分析中發揮重要作用。臨床實驗室提供藥物基因組學測試來預測藥物療效、劑量需求和潛在的不良反應。

遠距醫療的成長趨勢

如今，人們更喜歡遠距醫療，因為即使醫生身處偏遠地區，它也可以幫助與醫生聯繫。他們還可以透過遠距醫療平台獲得臨床實驗室服務，減少醫療保健障礙並增加整體檢測量。透過遠距醫療遠距監控糖尿病等慢性病變得容易。臨床實驗室對於這種疾病的持續管理和改善患者的治療結果非常重要。遠距醫療市場的主要參與者正在專注於合作和夥伴關係，以擴大其客戶群。例如，2023 年，Oracle 和 Zoom Video Communications, Inc. 擴大了合作範圍，以提供更快、更輕鬆、更有效的遠距醫療服務。臨床實驗室分發家庭試劑盒，然後處理在家收集的樣本，透過遠距醫療平台遠端提供準確的診斷結果，從而提供良好的臨床實驗室服務市場前景。

臨床實驗室服務市場細分：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據測試類型、服務提供者和應用程式對市場進行了分類。

按測試類型分類：

人類和腫瘤遺傳學

臨床化學

醫學微生物學和細胞學

其他

臨床化學佔據大部分市場佔有率

該報告根據測試類型提供了詳細的市場細分和分析。這包括人類和腫瘤遺傳學、臨床化學、醫學微生物學和細胞學等。根據該報告，臨床化學是最大的細分市場。

臨床化學可以定義為評估血液、尿液和其他體液的生化成分的廣泛測試。為了診斷和追蹤各種醫學疾病，這些測試很重要，因為它們可以提供有關荷爾蒙水平、器官功能、電解質平衡和代謝過程的重要資訊。慢性病患者的定期健康檢查和後續護理也包括大量的臨床化學檢測。為了評估一般健康狀況並發現問題，經常需要進行完整代謝組 (CMP) 和基本代謝組 (BMP) 等測試。

按服務提供者分類：

醫院實驗室

獨立實驗室

臨床實驗室

醫院實驗室佔據產業最大佔有率

報告還提供了基於服務提供者的詳細市場細分和分析。這包括醫院實驗室、獨立實驗室和診所實驗室。報告稱，醫院實驗室佔據最大的市場佔有率。

醫院實驗室是醫療保健設施的重要組成部分，因為它們與整個患者服務密切相關。在醫院環境中，他們為外科手術室、門診診所、住院患者和急診室的患者提供診斷服務。醫院實驗室通常提供多種診斷測試，以支援不同的患者人口統計和醫學專業。臨床化學、血液學、免疫學、微生物學、分子診斷和病理學服務都包含在內。他們為各種診斷測試要求提供一站式服務。

按應用分類：

生物分析與實驗室化學服務

毒理學測試服務

細胞和基因治療相關服務

臨床前和臨床試驗相關服務

藥物發現及開發相關服務

其他

生物分析和實驗室化學服務代表了領先的細分市場

該報告根據應用程式提供了詳細的市場細分和分析。這包括生物分析和實驗室化學服務、毒理學測試服務、細胞和基因治療相關服務、臨床前和臨床試驗相關服務、藥物發現和開發相關服務等。根據該報告，生物分析和實驗室化學服務佔最大的部分。

臨床診斷和生物醫學研究在很大程度上依賴生物分析和實驗室化學服務提供的廣泛測試和分析。這些實驗室提供的服務包括生物樣本中的生物標記、藥物濃度、代謝物和其他生化成分的測定。藥物動力學 (PK) 和藥效學 (PD) 研究是生物分析服務為製藥和生物技術產業提供的藥物開發過程中的兩個重要步驟。臨床實驗室提供生物分析服務，用於測量生物基質中的藥物濃度、評估臨床試驗中的藥物安全性和有效性以及評估藥物代謝。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美市場領先，佔據最大的臨床實驗室服務市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是臨床實驗室服務最大的區域市場。

北美擁有高度發展的醫療保健系統，擁有最先進的基礎設施和廣泛的醫療保健服務，特別是在美國和加拿大。這包括信譽良好的診所、醫院和診斷實驗室網路，提供廣泛的臨床實驗室服務。當談到全球醫療保健支出時，美國經常名列前茅。臨床實驗室服務的快速崛起可歸因於對醫療保健基礎設施、技術和服務的大量投資。疾病監測、定製藥物和診斷測試等市場驅動措施得到了醫療保健支出的支持。在美國營運的主要參與者也專注於提供支援新技術的測試。例如，2023 年，荷蘭生物技術公司 Detact Diagnostics 宣布計劃在其位於美國基恩州立學院的實驗室開始進行細菌檢測採樣。

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。臨床實驗室服務業的一些主要市場參與者包括 Abbott Laboratories、Becton、Dickinson and Company、bioMerieux SA、Charles River Laboratories、F. Hoffmann-La Roche Ltd、Illumina Inc.、NeoGenomics Laboratories Inc.、Quest Diagnostics Incorporated、西門子醫療保健有限公司(Siemens AG) 和Thermo Fisher Scientific Inc.

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

領先的臨床實驗室服務公司正在積極採取一系列策略來鞏固其在市場中的地位並滿足不斷成長的診斷測試需求。企業正在透過與其他公司合作以及透過收購擴大其服務組合來接觸全球更多的患者並提供更廣泛的測試選擇。例如，2023年，全球創新綜合實驗室服務領導者Labcorp宣布與馬薩諸塞州領先的綜合學術醫療系統Tufts Medicine達成協議，第一步收購Tufts Medicine外展實驗室業務並選擇營運資產邁向更大的策略夥伴關係。大公司也對自動化、數位病理學和下一代定序等尖端技術進行了大量投資，以提高其服務的精度、有效性和周轉時間。透過創建和利用基因和分子診斷的特定測試，他們還專注於客製化醫學，支持精準醫學和針對性治療。

臨床實驗室服務市場新聞：

2023 年：DiaCarta Ltd. 宣布，該公司已與新澤西州的Hopkins MedTech Compliance (HMC) 和Hopkins MedTech Lab Services (HML) 建立戰略合作夥伴關係，以支持監管合規性和實驗室開發測試(LDT) 驗證的未滿足需求。

2023 年：Aegis Sciences Corporation 收購了 HealthTrackRx 的毒理學業務部門，以增強其毒理學產品組合。

本報告回答的關鍵問題：

  • 迄今為止，全球臨床實驗室服務市場表現如何，未來幾年將如何表現？
  • 全球市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的市場？
  • 根據測試類型，市場的細分是什麼？
  • 市場上最具吸引力的測試類型是什麼？
  • 基於服務提供者的市場區隔是什麼？
  • 哪個是市場上最具吸引力的服務提供者？
  • 基於應用程式的市場區隔是什麼？
  • 市場上最有吸引力的應用是什麼？
  • 市場競爭結構如何？
  • 全球臨床實驗室服務市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 迄今為止，全球臨床實驗室服務市場表現如何，未來幾年將如何表現？
  • 全球市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球市場有何影響？
  • 主要區域市場有哪些？
  • 哪些國家代表了最具吸引力的市場？
  • 根據測試類型，市場的細分是什麼？
  • 市場上最具吸引力的測試類型是什麼？
  • 基於服務提供者的市場區隔是什麼？
  • 哪個是市場上最具吸引力的服務提供者？
  • 基於應用程式的市場區隔是什麼？
  • 市場上最有吸引力的應用是什麼？
  • 市場競爭結構如何？
  • 全球臨床實驗室服務市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球臨床實驗室服務市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按測試類型

  • 人類和腫瘤遺傳學
    • 市場趨勢
    • 市場預測
  • 臨床化學
    • 市場趨勢
    • 市場預測
  • 醫學微生物學和細胞學
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按服務供應商

  • 醫院實驗室
    • 市場趨勢
    • 市場預測
  • 獨立實驗室
    • 市場趨勢
    • 市場預測
  • 臨床實驗室
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按應用

  • 生物分析與實驗室化學服務
    • 市場趨勢
    • 市場預測
  • 毒理學測試服務
    • 市場趨勢
    • 市場預測
  • 細胞和基因治療相關服務
    • 市場趨勢
    • 市場預測
  • 臨床前和臨床試驗相關服務
    • 市場趨勢
    • 市場預測
  • 藥物發現及開發相關服務
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Charles River Laboratories
    • F. Hoffmann-La Roche Ltd
    • Illumina Inc.
    • NeoGenomics Laboratories Inc.
    • Quest Diagnostics Incorporated
    • Siemens Healthcare GmbH (Siemens AG)
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A3914

The global clinical laboratory services market size reached US$ 244.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 383.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032. The growing demand for diagnostic tests, such as blood glucose tests, HbA1c testing, and lipid profiles to manage diabetes, rising reliance on telehealth to access clinical laboratory services as it can reduce barriers to healthcare and increase overall testing volumes, and increasing trend of precision medicines are positively influencing the market.

Clinical Laboratory Services Market Analysis:

Major Market Drivers: The rising need for genetic testing, genomic sequencing, and molecular diagnostics to identify biomarkers, genetic variations, and specific molecular targets for precision medicines is propelling the market growth.

Key Market Trends: The growing trend of telehealth, which enable people to access healthcare services even at remote locations is offering a favorable market outlook.

Geographical Trends: North America is enjoying the leading position on account of its highly developed healthcare systems with cutting-edge infrastructure and widespread access to healthcare services.

Competitive Landscape: Some of the major market players in the clinical laboratory services industry include Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Charles River Laboratories, F. Hoffmann-La Roche Ltd, Illumina Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Incorporated, Siemens Healthcare GmbH (Siemens AG), Thermo Fisher Scientific Inc., among many others.

Challenges and Opportunities: While the market faces challenges, such as regulatory compliance, high operational costs, and maintaining accuracy and reliability of tests, it also encounters opportunities in diagnostic technologies, personalized medicine, and remote diagnostic services.

Clinical Laboratory Services Market Trends:

Rising prevalence of diabetes

There is a rise in the demand for diagnostic tests, such as blood glucose tests, HbA1c testing, and lipid profiles, to manage diabetes. These tests are also crucial for diagnosing diabetes, monitoring blood sugar levels, and assessing associated cardiovascular risk factors. To effectively manage diabetes, there is a need of monitoring blood glucose levels regularly. Clinical laboratories are very essential as they can help in monitoring glycemic control, kidney function, lipid levels, and other biomarkers. For preventing complications, such as diabetic retinopathy, nephropathy, and neuropathy, clinical laboratories perform screening tests. These screening tests allow for timely intervention that can assist in preventing progression of diabetes. People are preferring point-of-care testing (POCT) as it allows rapid testing and immediate results. This testing is more successful for monitoring patients with diabetes. As per the data published on the website of IDF Diabetes Atlas, it is projected that around 783 million people will be suffering from diabetes by 2045.

Growing demand for precision medicine

The IMARC Group's report shows that the global precision medicine market reached US$ 75.2 Billion in 2023. Genetic testing, genomic sequencing, and molecular diagnostics are important for precision medicines to identify biomarkers, genetic variations, and specific molecular targets. These tests are performed in clinical laboratories, as they help in predicting disease risks, selecting most effective therapies as individual's genetic characteristics, and guiding treatment decisions. To develop and perform companion diagnostics, clinical laboratories are very crucial, which is strengthening the clinical laboratory services market growth. Companion diagnostics are tests used to identify biomarkers to calculate the success rate of any specific targeted therapy. After knowing this, treatment choices in oncology, infectious diseases, and other therapeutic areas can be optimized. It is very important to analyze genetic variations to monitor the respond of medications in individuals, and pharmacogenomic plays an important role in this analysis. Clinical laboratories provide pharmacogenomic testing to predict drug efficacy, dosage requirements, and potential adverse reactions.

Increasing trend of telehealth

People are preferring telehealth nowadays, as it can help connect with doctors even if they are at remote locations. They can also access clinical laboratory services through telehealth platforms, reducing barriers to healthcare and increasing overall testing volumes. It becomes easy to monitor chronic conditions like diabetes remotely through telehealth. Clinical laboratories are very important for the ongoing management of this diseases and improving patient outcomes. Key players operating in the telehealth market are focusing on collaborations and partnerships to expand their customer base. For instance, in 2023, Oracle and Zoom Video Communications, Inc. expanded their collaboration to deliver faster, easier, and more effective telehealth services. Home-based kits are distributed by clinical laboratories and then they process the samples collected at home to provide accurate diagnostic results remotely through telehealth platforms, thereby offering a favorable clinical laboratory services market outlook.

Clinical Laboratory Services Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on test type, service provider, and application.

Breakup by Test Type:

Human and Tumor Genetics

Clinical Chemistry

Medical Microbiology and Cytology

Others

Clinical chemistry accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the test type. This includes human and tumor genetics, clinical chemistry, medical microbiology and cytology, and others. According to the report, clinical chemistry represents the largest segment.

Clinical chemistry can be defined as a broad range of tests that assess the biochemical components of blood, urine, and other bodily fluids. To diagnose and track a variety of medical disorders, these tests are important as they can provide vital information on hormone levels, organ function, electrolyte balance, and metabolic processes. Regular health screenings and follow-up care for patients with chronic diseases also include a large number of clinical chemistry tests. To evaluate general health status and identify problems, tests such as complete metabolic panels (CMP) and basic metabolic panels (BMP) are frequently ordered.

Breakup by Service Provider:

Hospital-Based Laboratories

Stand-Alone Laboratories

Clinic-Based Laboratories

Hospital-based laboratories hold the largest share of the industry

A detailed breakup and analysis of the market based on the service provider have also been provided in the report. This includes hospital-based laboratories, stand-alone laboratories, and clinic-based laboratories. According to the report, hospital-based laboratories account for the largest market share.

Hospital-based laboratories are essential components of healthcare facilities because they are closely linked to the whole range of patient services. Within the hospital setting, they provide diagnostic services for surgical units, outpatient clinics, inpatients, and patients in the emergency room. A wide variety of diagnostic tests are usually available at hospital laboratories to support different patient demographics and medical specialties. Clinical chemistry, hematology, immunology, microbiology, molecular diagnostics, and pathology services are all included in this. They offer a one-stop shop for a variety of diagnostic testing requirements.

Breakup by Application:

Bioanalytical and Lab Chemistry Services

Toxicology Testing Services

Cell and Gene Therapy Related Services

Preclinical and Clinical Trial Related Services

Drug Discovery and Development Related Services

Others

Bioanalytical and lab chemistry services represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes bioanalytical and lab chemistry services, toxicology testing services, cell and gene therapy related services, preclinical and clinical trial related services, drug discovery and development related services, and others. According to the report, bioanalytical and lab chemistry services represent the largest segment.

Clinical diagnostics and biomedical research depend heavily on a wide range of tests and analyses that are provided by bioanalytical and lab chemistry services. Assays for biomarkers, drug concentrations, metabolites, and other biochemical components in biological samples are among the services provided by these labs. Pharmacokinetic (PK) and pharmacodynamic (PD) investigations are two important steps in the drug development process that bioanalytical services provide for the pharmaceutical and biotechnology industries. Clinical laboratories offer bioanalytical services for measuring drug concentrations in biological matrices, evaluating medication safety and efficacy in clinical trials, and assessing drug metabolism.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest clinical laboratory services market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for clinical laboratory services.

North America has highly developed healthcare systems with cutting-edge infrastructure and widespread access to healthcare services, especially in the United States and Canada. This includes a reputable network of clinics, hospitals, and diagnostic labs that provide a wide range of clinical laboratory services. When it comes to healthcare spending worldwide, the US regularly comes in top. The rapid rise of clinical laboratory services can be attributed to the significant investments made in healthcare infrastructure, technology, and services. The market-driving initiatives of illness monitoring, tailored medication, and diagnostic testing are bolstered by healthcare spending. Key players operating in US also focusing on providing tests that support novel technology. For instance, in 2023, Dutch biotech firm Detact Diagnostics' announced about its plans to begin bacterial detection sampling at its laboratory in the Keene State College situated in the US.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the clinical laboratory services industry include Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Charles River Laboratories, F. Hoffmann-La Roche Ltd, Illumina Inc., NeoGenomics Laboratories Inc., Quest Diagnostics Incorporated, Siemens Healthcare GmbH (Siemens AG), and Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Leading clinical laboratory services companies are aggressively pursuing a range of tactics to fortify their positions in the market and satisfy the expanding need for diagnostic tests. Businesses are reaching more patients worldwide and providing a wider choice of tests by partnering with other companies and increasing their service portfolios through acquisitions. For instance, in 2023, Labcorp, a global leader of innovative and comprehensive laboratory services, announced an agreement with Tufts Medicine, a leading integrated academic health system in Massachusetts, to acquire the Tufts Medicine outreach laboratory business and select operating assets as a first step towards a larger strategic partnership. Major firms are also making significant investments in cutting-edge technologies including automation, digital pathology, and next-generation sequencing to increase the precision, effectiveness, and turnaround times of their services. By creating and utilizing specific tests for genetic and molecular diagnostics, they are also concentrating on customized medicine, which supports precision medicine and focused therapeutics.

Clinical Laboratory Services Market News:

In 2023: DiaCarta Ltd. announced that the company has formed strategic partnership with New Jersey-based Hopkins MedTech Compliance (HMC) and Hopkins MedTech Lab Services (HML) to support the unmet needs for regulatory compliance and laboratory developed test (LDT) validation of in vitro diagnostics (IVD) in the United States.

In 2023: Aegis Sciences Corporation acquired HealthTrackRx's Toxicology business unit to enhance its toxicology portfolio.

Key Questions Answered in This Report:

  • How has the global clinical laboratory services market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global market?
  • What is the impact of each driver, restraint, and opportunity on the global market?
  • What are the key regional markets?
  • Which countries represent the most attractive market?
  • What is the breakup of the market based on the test type?
  • Which is the most attractive test type in the market?
  • What is the breakup of the market based on the service provider?
  • Which is the most attractive service provider in the market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global clinical laboratory services market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clinical Laboratory Services Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Human and Tumor Genetics
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Clinical Chemistry
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Medical Microbiology and Cytology
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Service Provider

  • 7.1 Hospital-Based Laboratories
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Stand-Alone Laboratories
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Clinic-Based Laboratories
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Bioanalytical and Lab Chemistry Services
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Toxicology Testing Services
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cell and Gene Therapy Related Services
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Preclinical and Clinical Trial Related Services
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Drug Discovery and Development Related Services
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton, Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Charles River Laboratories
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 F. Hoffmann-La Roche Ltd
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Illumina Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 NeoGenomics Laboratories Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Quest Diagnostics Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Siemens Healthcare GmbH (Siemens AG)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Thermo Fisher Scientific Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Clinical Laboratory Services Market: Major Drivers and Challenges
  • Figure 2: Global: Clinical Laboratory Services Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Clinical Laboratory Services Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Clinical Laboratory Services Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: Clinical Laboratory Services Market: Breakup by Service Provider (in %), 2023
  • Figure 6: Global: Clinical Laboratory Services Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Clinical Laboratory Services Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Clinical Laboratory Services (Human and Tumor Genetics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Clinical Laboratory Services (Human and Tumor Genetics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Clinical Laboratory Services (Clinical Chemistry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Clinical Laboratory Services (Clinical Chemistry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Clinical Laboratory Services (Medical Microbiology and Cytology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Clinical Laboratory Services (Medical Microbiology and Cytology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Clinical Laboratory Services (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Clinical Laboratory Services (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Clinical Laboratory Services (Hospital-Based Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Clinical Laboratory Services (Hospital-Based Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Clinical Laboratory Services (Stand-Alone Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Clinical Laboratory Services (Stand-Alone Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Clinical Laboratory Services (Clinic-Based Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Clinical Laboratory Services (Clinic-Based Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Clinical Laboratory Services (Bioanalytical and Lab Chemistry Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Clinical Laboratory Services (Bioanalytical and Lab Chemistry Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Clinical Laboratory Services (Toxicology Testing Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Clinical Laboratory Services (Toxicology Testing Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Clinical Laboratory Services (Cell and Gene Therapy Related Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Clinical Laboratory Services (Cell and Gene Therapy Related Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Clinical Laboratory Services (Preclinical and Clinical Trial Related Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Clinical Laboratory Services (Preclinical and Clinical Trial Related Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Clinical Laboratory Services (Drug Discovery and Development Related Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Clinical Laboratory Services (Drug Discovery and Development Related Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Clinical Laboratory Services (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Clinical Laboratory Services (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: North America: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: North America: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: United States: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: United States: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Canada: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Canada: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia-Pacific: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia-Pacific: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: China: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: China: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Japan: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Japan: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: India: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: India: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: South Korea: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: South Korea: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Australia: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Australia: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Indonesia: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Indonesia: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Others: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Others: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Europe: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Europe: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Germany: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Germany: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: France: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: France: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: United Kingdom: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: United Kingdom: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Italy: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Italy: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Spain: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Spain: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Russia: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Russia: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Latin America: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Latin America: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Brazil: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Brazil: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Mexico: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Mexico: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Middle East and Africa: Clinical Laboratory Services Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Middle East and Africa: Clinical Laboratory Services Market: Breakup by Country (in %), 2023
  • Figure 82: Middle East and Africa: Clinical Laboratory Services Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Global: Clinical Laboratory Services Industry: SWOT Analysis
  • Figure 84: Global: Clinical Laboratory Services Industry: Value Chain Analysis
  • Figure 85: Global: Clinical Laboratory Services Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clinical Laboratory Services Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Clinical Laboratory Services Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 3: Global: Clinical Laboratory Services Market Forecast: Breakup by Service Provider (in Million US$), 2024-2032
  • Table 4: Global: Clinical Laboratory Services Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Clinical Laboratory Services Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Clinical Laboratory Services Market: Competitive Structure
  • Table 7: Global: Clinical Laboratory Services Market: Key Players